Skip to main content

Advertisement

Log in

Importance of the Cardio-Obstetrics Team

  • Pregnancy and Cardiovascular Disease (N Scott, Section Editor)
  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Abstract

Purpose

In the USA, maternal mortality has been rising since the 1980s. Cardiovascular disease is recognized as the leading cause of this worrisome trend, and a multidisciplinary approach to the care of patients with cardiovascular conditions during pregnancy is becoming increasingly important. We outline the literature supporting this multidisciplinary approach, highlight our center’s experience in building and expanding an integrated cardio-obstetrics practice, and provide guidance regarding patient selection and management within a combined practice.

Summary

Antenatal management patterns and delivery planning for patients with cardiovascular disease during pregnancy vary substantially among cardiovascular and obstetric and maternal fetal medicine practices in the USA. The need for multidisciplinary care between cardiologists and obstetricians is evident and has been supported by best practice statements from the American Heart Association, the American College of Obstetrics and Gynecology, and the Cardiac Disease in Pregnancy Study (CARPREG) investigators, whose CARPREG II risk score included “late first antenatal visit” as a predictor of adverse outcomes of pregnancy.

Conclusions

We have solid evidence supporting a multidisciplinary approach to the care of patients with cardiac conditions in pregnancy. This approach is optimal because it facilitates a consistent and clear message to the patient (and those caring for each patient) regarding management and risks associated with pregnancy, as well as subsequent risk and postpartum follow-up. We support the extension of clinical collaboration between obstetricians and cardiologists to the research realm and know that working together to investigate the outcomes of moms with heart conditions and their babies will provide clinically meaningful information to support the care of these unique patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References and Recommended Reading

  1. Centers for Disease Control and Prevention. Pregnancy mortality surveillance system.https://www.cdc.gov/reproductivehealth/maternalinfanthealth/pregnancy-mortality-surveillance-system.htm. Accessed August 13.

  2. Wolfe DS, Hameed AB, Taub CC, Zaidi AN, Bortnick AE. Addressing maternal mortality: the pregnant cardiac patient. Am J Obstet Gynecol. 2019;220(2):167.e161–8.

  3. Florio K, Daming TB, Grodzinsky A. Poorly understood maternal risks of pregnancy in women with heart disease. Circulation. 2018;137(8):766–8.

  4. Ramage K, Grabowska K, Silversides C, Quan H, Metcalfe A. Association of adult congenital heart disease with pregnancy, maternal, and neonatal outcomes. JAMA Netw Open. 2019;2(5):e193667.

  5. Davis MB, Walsh MN. Cardio-obstetrics. Circ Cardiovasc Qual Outcomes. 2019;12(2):e005417.

  6. Silversides CK, Grewal J, Mason J, Sermer M, Kiess M, Rychel V, et al. Pregnancy outcomes in women with heart disease: the CARPREG II study. J Am Coll Cardiol. 2018;71(21):2419–30.

  7. Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2019;139(14):e637–97.

  8. Brown HL, Warner JJ, Gianos E, Gulati M, Hill AJ, Hollier LM, et al. Promoting risk identification and reduction of cardiovascular disease in women through collaboration with obstetricians and gynecologists: a presidential advisory from the American Heart Association and the American College of Obstetricians and Gynecologists. Circulation. 2018;137(24):e843–52.

  9. Grodzinsky A, Florio K, Spertus JA, Daming T, Schmidt L, Lee J, et al. Maternal mortality in the United States and the HOPE Registry. Curr Treatment Options Cardiovasc Med. 2019;21(9):42.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anna Grodzinsky MD MS.

Ethics declarations

Conflict of Interest

Anna Grodzinsky, Karen Florio, John A. Spertus, Tara Daming, John Lee, Valerie Rader, Lynne Nelson, Rebecca Gray, Darcy White, Kate Swearingen, Merrill Thomas, Annapoorna Singh, Anthony Magalski, and Laura Schmidt each declare no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Pregnancy and Cardiovascular Disease

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grodzinsky, A., Florio, K., Spertus, J.A. et al. Importance of the Cardio-Obstetrics Team. Curr Treat Options Cardio Med 21, 84 (2019). https://doi.org/10.1007/s11936-019-0789-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11936-019-0789-1

Keywords

Navigation